APO Research
Talk to an analyst

APO RESEARCH · REPORT

Trastuzumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Trastuzumab Market Analysis and Forecast 2026-2032

26 December 2025191 pages

Choose your research edition.

Industry ResearchTrastuzumab Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Trastuzumab Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Trastuzumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Trastuzumab Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Trastuzumab Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Trastuzumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Trastuzumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Trastuzumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Trastuzumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Trastuzumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Trastuzumab include Novartis AG, Pfizer, InvivoGen, Genentech Inc, Celltrion, Bio-Techne, Biocon Limited and Abnova Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Trastuzumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Trastuzumab, also provides the sales of main regions and countries. Of the upcoming market potential for Trastuzumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Trastuzumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Trastuzumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Trastuzumab sales, projected growth trends, production technology, application and end-user industry.

Trastuzumab Segment by Company

Novartis AG

Pfizer

InvivoGen

Genentech Inc

Celltrion

Bio-Techne

Biocon Limited

Abnova Corporation

Trastuzumab Segment by Type

Human Source

Animal Source

Trastuzumab Segment by Application

Hospital

Medical Center

Trastuzumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trastuzumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Trastuzumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trastuzumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Trastuzumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Trastuzumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Trastuzumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Trastuzumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Human Source Major Manufacturers Table 3. Animal Source Major Manufacturers Table 4. Global Trastuzumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Medical Center Major Manufacturers Table 7. Trastuzumab Industry Trends Table 8. Trastuzumab Industry Drivers Table 9. Trastuzumab Industry Opportunities and Challenges Table 10. Trastuzumab Industry Restraints Table 11. Global Trastuzumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Trastuzumab Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Trastuzumab Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Trastuzumab Revenue Market Share by Region (2021-2026) Table 15. Global Trastuzumab Revenue Market Share by Region (2027-2032) Table 16. Global Trastuzumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 17. Global Trastuzumab Sales by Region (2021-2026) & (Tons) Table 18. Global Trastuzumab Sales by Region (2027-2032) & (Tons) Table 19. Global Trastuzumab Sales Market Share by Region (2021-2026) Table 20. Global Trastuzumab Sales Market Share by Region (2027-2032) Table 21. Global Trastuzumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Trastuzumab Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Trastuzumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Trastuzumab Sales Market Share by Manufacturers (2021-2026) Table 25. Global Trastuzumab Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 26. Global Trastuzumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Trastuzumab Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Trastuzumab Manufacturers, Product Type & Application Table 29. Global Trastuzumab Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Trastuzumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Trastuzumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Trastuzumab Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Trastuzumab Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Trastuzumab Revenue Market Share by Type (2021-2026) Table 36. Global Trastuzumab Revenue Market Share by Type (2027-2032) Table 37. Global Trastuzumab Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 38. Global Trastuzumab Sales by Type (2021-2026) & (Tons) Table 39. Global Trastuzumab Sales by Type (2027-2032) & (Tons) Table 40. Global Trastuzumab Sales Market Share by Type (2021-2026) Table 41. Global Trastuzumab Sales Market Share by Type (2027-2032) Table 42. Global Trastuzumab Price by Type (2021-2026) & (US$/Ton) Table 43. Global Trastuzumab Price by Type (2027-2032) & (US$/Ton) Table 44. Global Trastuzumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Trastuzumab Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Trastuzumab Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Trastuzumab Revenue Market Share by Application (2021-2026) Table 48. Global Trastuzumab Revenue Market Share by Application (2027-2032) Table 49. Global Trastuzumab Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 50. Global Trastuzumab Sales by Application (2021-2026) & (Tons) Table 51. Global Trastuzumab Sales by Application (2027-2032) & (Tons) Table 52. Global Trastuzumab Sales Market Share by Application (2021-2026) Table 53. Global Trastuzumab Sales Market Share by Application (2027-2032) Table 54. Global Trastuzumab Price by Application (2021-2026) & (US$/Ton) Table 55. Global Trastuzumab Price by Application (2027-2032) & (US$/Ton) Table 56. Novartis AG Company Information Table 57. Novartis AG Business Overview Table 58. Novartis AG Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 59. Novartis AG Trastuzumab Product Portfolio Table 60. Novartis AG Recent Development Table 61. Pfizer Company Information Table 62. Pfizer Business Overview Table 63. Pfizer Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 64. Pfizer Trastuzumab Product Portfolio Table 65. Pfizer Recent Development Table 66. InvivoGen Company Information Table 67. InvivoGen Business Overview Table 68. InvivoGen Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. InvivoGen Trastuzumab Product Portfolio Table 70. InvivoGen Recent Development Table 71. Genentech Inc Company Information Table 72. Genentech Inc Business Overview Table 73. Genentech Inc Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Genentech Inc Trastuzumab Product Portfolio Table 75. Genentech Inc Recent Development Table 76. Celltrion Company Information Table 77. Celltrion Business Overview Table 78. Celltrion Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Celltrion Trastuzumab Product Portfolio Table 80. Celltrion Recent Development Table 81. Bio-Techne Company Information Table 82. Bio-Techne Business Overview Table 83. Bio-Techne Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Bio-Techne Trastuzumab Product Portfolio Table 85. Bio-Techne Recent Development Table 86. Biocon Limited Company Information Table 87. Biocon Limited Business Overview Table 88. Biocon Limited Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Biocon Limited Trastuzumab Product Portfolio Table 90. Biocon Limited Recent Development Table 91. Abnova Corporation Company Information Table 92. Abnova Corporation Business Overview Table 93. Abnova Corporation Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Abnova Corporation Trastuzumab Product Portfolio Table 95. Abnova Corporation Recent Development Table 96. North America Trastuzumab Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Trastuzumab Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Trastuzumab Sales by Type (2021-2026) & (Tons) Table 99. North America Trastuzumab Sales by Type (2027-2032) & (Tons) Table 100. North America Trastuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 101. North America Trastuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 102. North America Trastuzumab Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Trastuzumab Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Trastuzumab Sales by Application (2021-2026) & (Tons) Table 105. North America Trastuzumab Sales by Application (2027-2032) & (Tons) Table 106. North America Trastuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 107. North America Trastuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 108. North America Trastuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Trastuzumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. North America Trastuzumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. North America Trastuzumab Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 112. North America Trastuzumab Sales by Country (2021-2026) & (Tons) Table 113. North America Trastuzumab Sales by Country (2027-2032) & (Tons) Table 114. North America Trastuzumab Sales Price by Country (2021-2026) & (US$/Ton) Table 115. North America Trastuzumab Sales Price by Country (2027-2032) & (US$/Ton) Table 116. United States Trastuzumab Revenue (2021-2032) & (US$ Million) Table 117. Canada Trastuzumab Revenue (2021-2032) & (US$ Million) Table 118. Mexico Trastuzumab Revenue (2021-2032) & (US$ Million) Table 119. Europe Trastuzumab Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Trastuzumab Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Trastuzumab Sales by Type (2021-2026) & (Tons) Table 122. Europe Trastuzumab Sales by Type (2027-2032) & (Tons) Table 123. Europe Trastuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 124. Europe Trastuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 125. Europe Trastuzumab Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Trastuzumab Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Trastuzumab Sales by Application (2021-2026) & (Tons) Table 128. Europe Trastuzumab Sales by Application (2027-2032) & (Tons) Table 129. Europe Trastuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 130. Europe Trastuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 131. Europe Trastuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Trastuzumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe Trastuzumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe Trastuzumab Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 135. Europe Trastuzumab Sales by Country (2021-2026) & (Tons) Table 136. Europe Trastuzumab Sales by Country (2027-2032) & (Tons) Table 137. Europe Trastuzumab Sales Price by Country (2021-2026) & (US$/Ton) Table 138. Europe Trastuzumab Sales Price by Country (2027-2032) & (US$/Ton) Table 139. Germany Trastuzumab Revenue (2021-2032) & (US$ Million) Table 140. France Trastuzumab Revenue (2021-2032) & (US$ Million) Table 141. U.K. Trastuzumab Revenue (2021-2032) & (US$ Million) Table 142. Italy Trastuzumab Revenue (2021-2032) & (US$ Million) Table 143. Russia Trastuzumab Revenue (2021-2032) & (US$ Million) Table 144. Spain Trastuzumab Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Trastuzumab Revenue (2021-2032) & (US$ Million) Table 146. Switzerland Trastuzumab Revenue (2021-2032) & (US$ Million) Table 147. Sweden Trastuzumab Revenue (2021-2032) & (US$ Million) Table 148. Poland Trastuzumab Revenue (2021-2032) & (US$ Million) Table 149. China Trastuzumab Revenue by Type (2021-2026) & (US$ Million) Table 150. China Trastuzumab Revenue by Type (2027-2032) & (US$ Million) Table 151. China Trastuzumab Sales by Type (2021-2026) & (Tons) Table 152. China Trastuzumab Sales by Type (2027-2032) & (Tons) Table 153. China Trastuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 154. China Trastuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 155. China Trastuzumab Revenue by Application (2021-2026) & (US$ Million) Table 156. China Trastuzumab Revenue by Application (2027-2032) & (US$ Million) Table 157. China Trastuzumab Sales by Application (2021-2026) & (Tons) Table 158. China Trastuzumab Sales by Application (2027-2032) & (Tons) Table 159. China Trastuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 160. China Trastuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 161. Asia Trastuzumab Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Trastuzumab Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Trastuzumab Sales by Type (2021-2026) & (Tons) Table 164. Asia Trastuzumab Sales by Type (2027-2032) & (Tons) Table 165. Asia Trastuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 166. Asia Trastuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 167. Asia Trastuzumab Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Trastuzumab Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Trastuzumab Sales by Application (2021-2026) & (Tons) Table 170. Asia Trastuzumab Sales by Application (2027-2032) & (Tons) Table 171. Asia Trastuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 172. Asia Trastuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 173. Asia Trastuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Trastuzumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Trastuzumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Trastuzumab Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 177. Asia Trastuzumab Sales by Country (2021-2026) & (Tons) Table 178. Asia Trastuzumab Sales by Country (2027-2032) & (Tons) Table 179. Asia Trastuzumab Sales Price by Country (2021-2026) & (US$/Ton) Table 180. Asia Trastuzumab Sales Price by Country (2027-2032) & (US$/Ton) Table 181. Japan Trastuzumab Revenue (2021-2032) & (US$ Million) Table 182. South Korea Trastuzumab Revenue (2021-2032) & (US$ Million) Table 183. India Trastuzumab Revenue (2021-2032) & (US$ Million) Table 184. Australia Trastuzumab Revenue (2021-2032) & (US$ Million) Table 185. Taiwan Trastuzumab Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Trastuzumab Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Trastuzumab Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Trastuzumab Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Trastuzumab Sales by Type (2021-2026) & (Tons) Table 190. SAMEA Trastuzumab Sales by Type (2027-2032) & (Tons) Table 191. SAMEA Trastuzumab Sales Price by Type (2021-2026) & (US$/Ton) Table 192. SAMEA Trastuzumab Sales Price by Type (2027-2032) & (US$/Ton) Table 193. SAMEA Trastuzumab Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Trastuzumab Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Trastuzumab Sales by Application (2021-2026) & (Tons) Table 196. SAMEA Trastuzumab Sales by Application (2027-2032) & (Tons) Table 197. SAMEA Trastuzumab Sales Price by Application (2021-2026) & (US$/Ton) Table 198. SAMEA Trastuzumab Sales Price by Application (2027-2032) & (US$/Ton) Table 199. SAMEA Trastuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Trastuzumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Trastuzumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Trastuzumab Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 203. SAMEA Trastuzumab Sales by Country (2021-2026) & (Tons) Table 204. SAMEA Trastuzumab Sales by Country (2027-2032) & (Tons) Table 205. SAMEA Trastuzumab Sales Price by Country (2021-2026) & (US$/Ton) Table 206. SAMEA Trastuzumab Sales Price by Country (2027-2032) & (US$/Ton) Table 207. Brazil Trastuzumab Revenue (2021-2032) & (US$ Million) Table 208. Argentina Trastuzumab Revenue (2021-2032) & (US$ Million) Table 209. Chile Trastuzumab Revenue (2021-2032) & (US$ Million) Table 210. Colombia Trastuzumab Revenue (2021-2032) & (US$ Million) Table 211. Peru Trastuzumab Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Trastuzumab Revenue (2021-2032) & (US$ Million) Table 213. Israel Trastuzumab Revenue (2021-2032) & (US$ Million) Table 214. UAE Trastuzumab Revenue (2021-2032) & (US$ Million) Table 215. Turkey Trastuzumab Revenue (2021-2032) & (US$ Million) Table 216. Iran Trastuzumab Revenue (2021-2032) & (US$ Million) Table 217. Egypt Trastuzumab Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Trastuzumab Distributors List Table 221. Trastuzumab Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Trastuzumab Image Figure 2. Global Trastuzumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Trastuzumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. Human Source Image Figure 5. Animal Source Image Figure 6. Global Trastuzumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Trastuzumab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Medical Center Image Figure 10. Global Trastuzumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Trastuzumab Revenue (2021-2032) & (US$ Million) Figure 12. Global Trastuzumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Trastuzumab Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Trastuzumab Revenue Market Share by Region (2021-2032) Figure 15. Global Trastuzumab Sales (2021-2032) & (Tons) Figure 16. Global Trastuzumab Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 17. Global Trastuzumab Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Trastuzumab Sales YoY (2021-2032) & (Tons) Figure 19. Europe Trastuzumab Sales YoY (2021-2032) & (Tons) Figure 20. China Trastuzumab Sales YoY (2021-2032) & (Tons) Figure 21. Asia (Excluding China) Trastuzumab Sales YoY (2021-2032) & (Tons) Figure 22. South America, Middle East and Africa Trastuzumab Sales YoY (2021-2032) & (Tons) Figure 23. Global Trastuzumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Trastuzumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Trastuzumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Trastuzumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Trastuzumab Revenue Market Share by Type (2021-2032) Figure 29. Global Trastuzumab Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 30. Global Trastuzumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Trastuzumab Sales Market Share by Type (2021-2032) Figure 32. Global Trastuzumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Trastuzumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Trastuzumab Revenue Market Share by Application (2021-2032) Figure 35. Global Trastuzumab Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 36. Global Trastuzumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Trastuzumab Sales Market Share by Application (2021-2032) Figure 38. North America Trastuzumab Revenue Share by Type (2021-2032) Figure 39. North America Trastuzumab Sales Share by Type (2021-2032) Figure 40. North America Trastuzumab Revenue Share by Application (2021-2032) Figure 41. North America Trastuzumab Sales Share by Application (2021-2032) Figure 42. North America Trastuzumab Revenue Share by Country (2021-2032) Figure 43. North America Trastuzumab Sales Share by Country (2021-2032) Figure 44. Europe Trastuzumab Revenue Share by Type (2021-2032) Figure 45. Europe Trastuzumab Sales Share by Type (2021-2032) Figure 46. Europe Trastuzumab Revenue Share by Application (2021-2032) Figure 47. Europe Trastuzumab Sales Share by Application (2021-2032) Figure 48. Europe Trastuzumab Revenue Share by Country (2021-2032) Figure 49. Europe Trastuzumab Sales Share by Country (2021-2032) Figure 50. China Trastuzumab Revenue Share by Type (2021-2032) Figure 51. China Trastuzumab Sales Share by Type (2021-2032) Figure 52. China Trastuzumab Revenue Share by Application (2021-2032) Figure 53. China Trastuzumab Sales Share by Application (2021-2032) Figure 54. Asia Trastuzumab Revenue Share by Type (2021-2032) Figure 55. Asia Trastuzumab Sales Share by Type (2021-2032) Figure 56. Asia Trastuzumab Revenue Share by Application (2021-2032) Figure 57. Asia Trastuzumab Sales Share by Application (2021-2032) Figure 58. Asia Trastuzumab Revenue Share by Country (2021-2032) Figure 59. Asia Trastuzumab Sales Share by Country (2021-2032) Figure 60. SAMEA Trastuzumab Revenue Share by Type (2021-2032) Figure 61. SAMEA Trastuzumab Sales Share by Type (2021-2032) Figure 62. SAMEA Trastuzumab Revenue Share by Application (2021-2032) Figure 63. SAMEA Trastuzumab Sales Share by Application (2021-2032) Figure 64. SAMEA Trastuzumab Revenue Share by Country (2021-2032) Figure 65. SAMEA Trastuzumab Sales Share by Country (2021-2032) Figure 66. Trastuzumab Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Trastuzumab Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Human Source
  • Animal Source
Applications
  • Hospital
  • Medical Center
Companies covered
  • Novartis AG
  • Pfizer
  • InvivoGen
  • Genentech Inc
  • Celltrion
  • Bio-Techne
  • Biocon Limited
  • Abnova Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Trastuzumab Market by Type
  3. 1.2.1 Global Trastuzumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Human Source
  5. 1.2.3 Animal Source
  6. 1.3 Trastuzumab Market by Application
  7. 1.3.1 Global Trastuzumab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Medical Center
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Trastuzumab Market Dynamics
  1. 2.1 Trastuzumab Industry Trends
  2. 2.2 Trastuzumab Industry Drivers
  3. 2.3 Trastuzumab Industry Opportunities and Challenges
  4. 2.4 Trastuzumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Trastuzumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Trastuzumab Revenue by Region
  3. 3.2.1 Global Trastuzumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Trastuzumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Trastuzumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Trastuzumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Trastuzumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Trastuzumab Sales by Region
  9. 3.4.1 Global Trastuzumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Trastuzumab Sales by Region (2021-2026)
  11. 3.4.3 Global Trastuzumab Sales by Region (2027-2032)
  12. 3.4.4 Global Trastuzumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Trastuzumab Revenue by Manufacturers
  2. 4.1.1 Global Trastuzumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Trastuzumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Trastuzumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Trastuzumab Sales by Manufacturers
  6. 4.2.1 Global Trastuzumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Trastuzumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Trastuzumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Trastuzumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Trastuzumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Trastuzumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Trastuzumab Manufacturers, Product Type & Application
  13. 4.7 Global Trastuzumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Trastuzumab Market CR5 and HHI
  16. 4.8.2 2025 Trastuzumab Tier 1, Tier 2, and Tier 3
5 Trastuzumab Market by Type
  1. 5.1 Global Trastuzumab Revenue by Type
  2. 5.1.1 Global Trastuzumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Trastuzumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Trastuzumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Trastuzumab Sales by Type
  6. 5.2.1 Global Trastuzumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Trastuzumab Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Trastuzumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Trastuzumab Price by Type
6 Trastuzumab Market by Application
  1. 6.1 Global Trastuzumab Revenue by Application
  2. 6.1.1 Global Trastuzumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Trastuzumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Trastuzumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Trastuzumab Sales by Application
  6. 6.2.1 Global Trastuzumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Trastuzumab Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Trastuzumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Trastuzumab Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Trastuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Trastuzumab Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Trastuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Trastuzumab Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 InvivoGen
  14. 7.3.1 InvivoGen Company Information
  15. 7.3.2 InvivoGen Business Overview
  16. 7.3.3 InvivoGen Trastuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 InvivoGen Trastuzumab Product Portfolio
  18. 7.3.5 InvivoGen Recent Developments
  19. 7.4 Genentech Inc
  20. 7.4.1 Genentech Inc Company Information
  21. 7.4.2 Genentech Inc Business Overview
  22. 7.4.3 Genentech Inc Trastuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Genentech Inc Trastuzumab Product Portfolio
  24. 7.4.5 Genentech Inc Recent Developments
  25. 7.5 Celltrion
  26. 7.5.1 Celltrion Company Information
  27. 7.5.2 Celltrion Business Overview
  28. 7.5.3 Celltrion Trastuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Celltrion Trastuzumab Product Portfolio
  30. 7.5.5 Celltrion Recent Developments
  31. 7.6 Bio-Techne
  32. 7.6.1 Bio-Techne Company Information
  33. 7.6.2 Bio-Techne Business Overview
  34. 7.6.3 Bio-Techne Trastuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Techne Trastuzumab Product Portfolio
  36. 7.6.5 Bio-Techne Recent Developments
  37. 7.7 Biocon Limited
  38. 7.7.1 Biocon Limited Company Information
  39. 7.7.2 Biocon Limited Business Overview
  40. 7.7.3 Biocon Limited Trastuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Biocon Limited Trastuzumab Product Portfolio
  42. 7.7.5 Biocon Limited Recent Developments
  43. 7.8 Abnova Corporation
  44. 7.8.1 Abnova Corporation Company Information
  45. 7.8.2 Abnova Corporation Business Overview
  46. 7.8.3 Abnova Corporation Trastuzumab Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Abnova Corporation Trastuzumab Product Portfolio
  48. 7.8.5 Abnova Corporation Recent Developments
8 North America
  1. 8.1 North America Trastuzumab Market Size by Type
  2. 8.1.1 North America Trastuzumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Trastuzumab Sales by Type (2021-2032)
  4. 8.1.3 North America Trastuzumab Price by Type (2021-2032)
  5. 8.2 North America Trastuzumab Market Size by Application
  6. 8.2.1 North America Trastuzumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Trastuzumab Sales by Application (2021-2032)
  8. 8.2.3 North America Trastuzumab Price by Application (2021-2032)
  9. 8.3 North America Trastuzumab Market Size by Country
  10. 8.3.1 North America Trastuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Trastuzumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Trastuzumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Trastuzumab Market Size by Type
  2. 9.1.1 Europe Trastuzumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Trastuzumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Trastuzumab Price by Type (2021-2032)
  5. 9.2 Europe Trastuzumab Market Size by Application
  6. 9.2.1 Europe Trastuzumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Trastuzumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Trastuzumab Price by Application (2021-2032)
  9. 9.3 Europe Trastuzumab Market Size by Country
  10. 9.3.1 Europe Trastuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Trastuzumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Trastuzumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Trastuzumab Market Size by Type
  2. 10.1.1 China Trastuzumab Revenue by Type (2021-2032)
  3. 10.1.2 China Trastuzumab Sales by Type (2021-2032)
  4. 10.1.3 China Trastuzumab Price by Type (2021-2032)
  5. 10.2 China Trastuzumab Market Size by Application
  6. 10.2.1 China Trastuzumab Revenue by Application (2021-2032)
  7. 10.2.2 China Trastuzumab Sales by Application (2021-2032)
  8. 10.2.3 China Trastuzumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Trastuzumab Market Size by Type
  2. 11.1.1 Asia Trastuzumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Trastuzumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Trastuzumab Price by Type (2021-2032)
  5. 11.2 Asia Trastuzumab Market Size by Application
  6. 11.2.1 Asia Trastuzumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Trastuzumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Trastuzumab Price by Application (2021-2032)
  9. 11.3 Asia Trastuzumab Market Size by Country
  10. 11.3.1 Asia Trastuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Trastuzumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Trastuzumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Trastuzumab Market Size by Type
  2. 12.1.1 SAMEA Trastuzumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Trastuzumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Trastuzumab Price by Type (2021-2032)
  5. 12.2 SAMEA Trastuzumab Market Size by Application
  6. 12.2.1 SAMEA Trastuzumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Trastuzumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Trastuzumab Price by Application (2021-2032)
  9. 12.3 SAMEA Trastuzumab Market Size by Country
  10. 12.3.1 SAMEA Trastuzumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Trastuzumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Trastuzumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Trastuzumab Value Chain Analysis
  2. 13.1.1 Trastuzumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Trastuzumab Production Mode & Process
  6. 13.2 Trastuzumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Trastuzumab Distributors
  9. 13.2.3 Trastuzumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst